7d agoInvesting.com Analyst RatingsBEARISH 38Analyst
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
Archived explainer. For the current picture see today's ALHC page.
Why Is ALIGNMENT HEALTHCARE (ALHC) Stock Down Today?
By the Top Tier Newswire AI Desk · August 3, 2026 at 10:00 AM ET · reviewed against 2 wire stories
ALIGNMENT HEALTHCARE (ALHC) is down -5.62% in the latest session. Our newswire has captured 2 stories on ALHC across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why ALHC stock is down today
Alignment Healthcare stock closed down 5.62% at $14.02 on Friday, marking a significant decline driven by a downgrade from Raymond James. The firm cut its stock rating citing concerns over earnings visibility. The stock opened with a modest 0.7% gap up but quickly reversed course, hitting a session low of $13.98 before closing near that level. The move reflects broader investor caution following recent insider selling and mixed fundamental performance.
What Happened
Raymond James downgraded Alignment Healthcare stock due to uncertainty about future earnings visibility. This downgrade came amid recent insider transactions, with several top executives including the CEO and President selling shares. Additionally, a report from Modern Healthcare alleged that a former executive claimed the company manipulated its finances to boost stock price and executive compensation. While the company has shown strong revenue growth in recent quarters, including beating estimates in Q2 and raising full-year sales guidance, the net margin remains low at 0.9%. These factors combined to weigh on investor sentiment and drive the stock lower.
What The Data Shows
The stock has declined 26.7% over the last eight sessions, from $21.07 to $15.45, and currently trades within its 52-week range of $12.91 to $25.12. The session volume of 1.8 million shares was significantly below the 3-month average. Recent insider activity has been heavily tilted toward selling, with 11 reported sales totaling $24.7 million in the last 90 days. In contrast, only one insider buy was recorded for $198,000. Congressional trades show one buy of $15,001 to $50,000 by Donald J. Trump in May. Social chatter has been minimal, with no posts in the last 24 hours.
What To Watch
Investors should monitor the company’s upcoming earnings report for further insight into its financial health and guidance. Additionally, coverage breadth and any follow-up analyst actions will be key to assessing the stock’s near-term trajectory.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ALHC by the numbers
Last: $14.02Session: -5.62%7 sessions: -27.05%Coverage: 2 stories / 2 sourcesAI sentiment: 53/100 (mixed)Mkt cap: $3.1BP/E: 75.252w: $12.91 to $25.12
The headlines behind the move
7d agoYahoo FinanceBULLISH 67General
Speed as Strategy: Rabigh Reinforcement Delivers 1,179 MW on an Accelerated Timeline
Facing potential supply constraints along the Makkah-Jeddah corridor, Saudi Arabia’s power sector compressed a combined cycle schedule by months driven by early alignment, staged authorization, and
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ALHC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ALHC move explainers: 2026-08-04 · 2026-08-03 · 2026-07-31